First-In-Class Drugs Made Up More Than Half Of US FDA’s Novel Approvals Last Year

 
• By Bridget Silverman
  
FDA first in class
MOST NOVEL PRODUCTS THAT GRADUATED FROM FDA’s DRUG CENTER in 2021 WERE FIRST IN THEIR CLASS. • Source: Nielsen Hobbs; the Pink Sheet | Alamy image
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Approvals

More from Product Reviews